Navigation Links
Thalidomide may stage a comeback

The controversial drug thalidomide, which was banned in 1962, is being reassessed to find out if it could again be prescribed to patients to treat rare forms of cancer and leprosy. The drug which is unlicensed in Europe was marketed in the 50s and 60s as a cure for morning// sickness. However, it was banned after mothers who took it gave birth to deformed children.

The European Agency for the Evaluation of Medicinal Products (EMEA) is now considering whether the drug should be re-licensed for use across the EU, since recent studies have suggested that thalidomide could be a weapon in the fight against cancer and could help people with AIDS and other serious diseases. EMEA officials who met representatives of thalidomide victims as part of their consultation process, are focusing on the safeguards that would be needed if the drug is re-licensed.

The agency also suggested that even if the drug is approved, it will only be used on specific patients. These include patients diagnosed with multiple myeloma, a cancer of the bone marrow, which affects about 20,000 patients in Europe each year. Earlier, Dr. Claus Newman, a specialist in birth defects stated that thalidomide is a unique drug with powerful effects potentially for harm and good and its wider licensing will require extraordinary measures.


'"/>




Page: 1

Related medicine news :

1. Thalidomide is the new approved drug for treating multiple cancers
2. Thalidomide for Tumor Treatment
3. Frozen Canadian baby stages miraculous recovery
4. Surgery for early stage prostate cancer is better than waiting
5. Drug Tarceva for End-stage Lung cancer
6. Breast Cancer in younger women can be detected at an early stage by mammograms
7. Cancer cells were killed even at reduced dose of radiation therapy in early stage Hodgkin’s.
8. Herceptin is the cure for early stages of breast cancer?
9. Genes determine the capacity to fight HIV in early stages
10. Dialysis Trust Set Up in Bangalore by End-stage Kidney Patients
11. Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a ... it has partnered with WALLIX to expand its solution to help government ... There are a number of ways to address the authentication requirements within NIST ...
(Date:7/24/2017)... Solana Beach, California (PRWEB) , ... July 24, ... ... and commercialization of autologous fat (adipose) transfer systems announces the issuance of United ... (the ‘324 patent) for its adipose filtration technology. The '398 and '324 ...
(Date:7/24/2017)... Georgia (PRWEB) , ... July 24, 2017 , ... ... comprehensive sleep management solution focused on delivering end-to-end sleep health care ... program. , Recent literature shows that adherence rates for positive airway pressure (PAP) ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... today CURE announced that they have enrolled over 100,000 children in their treatment ... children born every year in areas where treatment is limited or non-existent. Without ...
(Date:7/24/2017)... Binzhou, Shandong Province (PRWEB) , ... July 24, ... ... Traditional Chinese Medicine's "Chinese Medicine Clinical Vitiligo Hospital" was set up, and the ... State Administration of traditional Chinese medicine, the head of the army's health system, ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology: